Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Transaction with shares in Curasight A/S made by managerial employee

COPENHAGEN – Curasight A/S (“Curasight” or “the Company”).  In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transaction made in Curasight made by managerial employee.The Company’s managerial employee have given Curasight power of attorney on her behalf to publish purchase of Curasight shares as managerial employee conducted 13 December 2021. The transaction comprise the following managerial employee; Name Position Aggregated volume Price, DKK

BioStock: BioInvent presents positive interim data

BioInvent has presented updated positive interim data from its phase I/II study with the anti-FcyRIIB antibody BI-1206. The current study evaluates BI-1206 in combination with rituximab for the treatment of patients with indolent non-Hodgkin's B-cell lymphoma. BioInvent will hold a Key Opinion Leader event on December 17 where this data will be discussed in more detail.Read the full article about BioInvent at biostock.se: https://www.biostock.se/en/2021/12/bioinvent-presents-positive-interim-data/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.

BioStock: Positive phase II results for Curasight in head and neck cancer

In their Q3-report, Danish Curasight signalled an upcoming interesting news flow. Two weeks later, the company started delivering on that promise with positive data coming from one of the investigator-initiated phase II studies with uTRACE, where the PET-tracer showed potential as a future tool in the treatment of head and neck cancer patients. BioStock reached out to Curasight CEO Ulrich Krasilnikoff to learn more.Read the full article at biostock.se:https://www.biostock.se/en/2021/12/positive-phase-ii-results-for-curasight-in-head-and-neck-cancer/This is a press release from BioStock -

Fortaco Group and Buisard Cabins to join forces

Fortaco Group and Buisard have joined forces and established the Fortaco Buisard Cabins entity within Fortaco Group. Through a strategic alliance, we create a market leading vehicle cabin technology and manufacturing business serving the off-highway equipment industry as part of Fortaco Group. The combined net sales of cabin business is +140 M€, while Fortaco Group total net sales, including Buisard is +340 M€. Business Sites locate in Holic/Slovakia, Kurikka/Finland, Sable-sur-Sarthe/France and Pune/India. Both Fortaco and Buisard have respected and complimentary customer portfolio, and

Modus Therapeutics participates in Aktier Live Sessions

Stockholm, Tuesday, December 14, 2021. Modus Therapeutics Holding AB ("Modus") announces that the company participates in today’s Aktier Live Sessions at 18:00.Modus' CEO John Öhd and CFO Claes Lindblad will be interviewed by Aktier Live Sessions Jonathan Furelid on Tuesday, December 14 at 18:00. The interview is streamed live with the opportunity to ask questions to the company directly in the chat. The company tells of an eventful year during which, among other things, the company was listed on the Nasdaq First North Growth market and started the first clinical study in the planned sepsis

Implantica successfully performs cadaver implantations of pipeline products and several related tests at the cadaver lab

Implantica AG (publ) announces today advances in development of its pipeline products at a cadaver lab in Germany.Prototypes of several of the company’s pipeline products have been implanted and tested in cadavers in order to determine key data points and advance development. The products that were tested include UriControl®, AppetiteControl™ and UriRestore® as well as a new version of RefluxStop™, which is designed to treat acid reflux in those patients undergoing a gastric sleeve procedure, representing approximately 600’000 procedures annually. “Cadaver implantations provide us with

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 13th December 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 26,573,000 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Pharmacolog expands into Mexico with Codonics

Pharmacolog and Codonics extend existing agreement to include sales of WasteLog® and associated services into Mexico.Pharmacolog and Codonics entered into a strategic agreement, appointing Codonics as the exclusive distributor of WasteLog® in the American and Canadian markets one year ago. Today, the company is announcing the agreement has been expanded to include Codonics distribution of WasteLog® into Mexico. WasteLog® is an analytical tool that enables a hospital pharmacy to assay narcotic waste to help prevent drug diversion. The use of opioids in healthcare in Mexico has increased

Nordea cancels repurchased shares

Nordea Bank AbpStock exchange release – Total number of voting rights and capital14 December 2021 at 9.15 EET Nordea Bank Abp (“Nordea”) has today cancelled 41,787,771 treasury shares, which were held for capital optimisation purposes and acquired through share buy-backs, in line with the decision by the Board of Directors. The cancellation of the treasury shares has been registered with the Finnish Trade Register on 14 December 2021. After the cancellation, the total number of shares in Nordea is 3,965,561,160 and the total number of votes attached to the shares is 3,965,561,160.

Viking Line Abp: Managers' Transactions

Viking Line Abp MANAGERS' TRANSACTIONS 14.12.2021, 9:15 AMManagers' transactionsViking Line Abp has on the 14th of December 2021 received the following notification pursuant to Article 19 of the EU Market Abuse Regulation from a person closely associated with a person discharging managerial responsibilities in Viking Line Abp. Viking Line Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Maelir ABPosition: Closely associated person (X) Legal person  (1):Person Discharging Managerial Responsibilities

Metsä Group donates a total of EUR 500,000 to the universities of Helsinki and Oulu

Metsä Group press release 14 December 2021Metsä Group has donated EUR 250,000 each to the University of Helsinki and the University of Oulu. These donations will be allocated to science, agriculture and forestry at the University of Helsinki and to technology at the University of Oulu. Metsä Group wants to invest in developing teaching and research in these fields.  “Metsä Group produces recyclable products from northern wood for the daily needs of people around the world. Sustainability, competitive production and the top expertise of our employees lie at the core of our operations. We

Axfood becomes new partner in Mathem as Mat.se and Mathem merge

Axfood and Mathem are entering into a strategic partnership, with Axfood divesting Mat.se in exchange for shares in Mathem, a strong pure-play online retailer with home delivery. At the same time, Mathem is entering into a long-term delivery partnership with Axfood’s purchasing and logistics company Dagab. The purchase consideration for Mat.se amounts to SEK 688 m on a cash and debt-free basis, and payment will take place through newly issued shares in Mathem corresponding to a shareholding of 16.5%.As part of this strategic partnership, Axfood AB (“Axfood”) has entered into an agreement to

Climeon Heat Power Production Initiated Onboard Maersk Container Vessel

Climeon AB announces the successful integration of the commissioned Heat Power System onboard a Maersk container vessel. Maersk will begin evaluating the waste heat recovery technology’s potential for increasing energy efficiency and strengthening their mission to achieve a 60% reduction in CO2 emissions by 2030. The maritime industry share of greenhouse gas (GHG) emissions is approximately 3%. “Business as usual” scenarios expecting to result in growth of GHG emissions by 20% or more by 2050, according to Mærsk Mc-Kinney Møller Center for Zero Carbon Shipping’s recently published

Plastic-degrading enzymes increasing in correlation with pollution

The number of microbial enzymes with the ability to degrade plastic is growing, in correlation with local levels of plastic pollution. That is the finding of a new study from Chalmers University of Technology, Sweden, that measured samples of environmental DNA from around the globe. The results illustrate the impact plastic pollution is having on the environment, and hint at potential new solutions for managing the problem. The problems of global plastic pollution are all too widespread, as mass-production of plastic has exploded in the last 70 years or so – from around 2 million

New financial goals for ITAB to be presented in conjunction with the financial statements 2021

As previously communicated, the Board of Directors works together with the Group Management of ITAB Shop Concept AB (publ) (“ITAB”) to formulate clear financial goals with a focus on growth and profitability. The intention is to present new financial targets for ITAB in conjunction with the financial statements for 2021.The new financial targets for ITAB will be set by the Board in conjunction with the annual financial statements and will be included in ITAB's Financial Report for 2021, which will be published on 8 February 2022. ”ITAB is well positioned for the next step in the

Metso Outotec's financial reporting and AGM in 2022

Metso Outotec Corporation’s stock exchange release on December 14, 2021, at 09:00 a.m. EETMetso Outotec Corporation will publish its financial reports in 2022 as follows: · Financial Statements Review for 2021 on February 10, 2022 · Annual Report for 2021 during the week of March 14 · Interim Report for January - March 2022 on April 21, 2022 · Half-Year Financial Report for January - June 2022 on July 21, 2022 · Interim Report for January – September 2022 on October 27, 2022 The Annual General Meeting is planned to be held on April 21, 2022. Metso Outotec’s Board of

Management change at Mycronic

Mycronic AB (publ) has appointed Johanna Jarl Senior Vice President Human Resources and member of the Corporate Management Team, joining no later than March 10, 2022.Johanna Jarl’s current role is as Vice President and Head of HR Infrastructure Division at AFRY, where she has also held other leading roles in HR, strategy and talent management. Previous to that Johanna worked at SSAB, most recently as Director Strategy & Integration SSAB Europe Division and at Accenture as management consultant in Talent & Organization. Johanna has a MSc in Business and Economics from Uppsala University. “

From crime scene to court: With the new release MSAB offers a truly secure end to end mobile forensics solution for the market

MSAB, a world leader in mobile forensics, announces the fourth major release for 2021. Together these updates create a complete security and integrity focused ecosystem. “MSAB offers a truly secure end to end mobile forensics solutions on the market to prevent and solve crimes around the world. We have a complete digital forensic ecosystem solution that maintains the integrity of recovering digital evidence from mobile devices while preserving fundamental rights to privacy”, says Joel Bollö, CEO of MSAB.The updated mobile forensics solution for digital data extraction, XRY 

Operational Update

14 December 2021 IOG plc Operational Update IOG plc ("IOG", or "the Company"), (AIM: IOG.L), the Net Zero UK gas and infrastructure operator focused on high return projects, provides a further operational and portfolio update. Andrew Hockey, CEO of IOG, commented:  "I am pleased to confirm the Noble Hans Deul rig re-mobilised from Dundee back to Southwark in early December as forecast following an efficient repair by Noble Corporation. I look forward to safe and successful execution of the Southwark wells, the first of which is expected to spud in the next week. Although

Konecranes now delivers hybrid and electric RTGs as carbon neutral

· First in industry to deliver products carbon neutral · Applicable worldwide to hybrid and electric RTGs ordered nowAs global concern about carbon emissions and climate change grows, Konecranes is taking significant action to reduce the CO\2\ emissions of its own operations and the carbon footprint of its products. As a world first in the container handling industry, Konecranes now delivers hybrid and electric RTGs to customers as carbon neutral. Carbon emissions have been minimized wherever possible, and where not possible they have been compensated for with re-forestation, up to the

Last day of trading in Cessatech’s warrants of series TO 1 is today Tuesday 14 December 2021

Copenhagen, Denmark, 14 December 2021 – Tuesday, 14 December 2021, is the last day of trading in warrants of series TO 1 on Spotlight Stock Market. The warrants of series TO 1 were issued in connection with Cessatech A/S (“Cessatech” or the “Company”) IPO of units that took place in November/December 2020. Each (1) warrant of series TO 1 entitles the holder to subscribe for one (1) new share in Cessatech. Last day to exercise the warrants of series TO 1 and subscribe for shares is 16 December 2021. Note that the banks/nominees need to be notified well in advance before the exercise period ends

BerGenBio to present at DNB Nordic Healthcare Conference 2021

Bergen, Norway, 14 December 2021 – BerGenBio ASA (OSE:BGBIO), BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, is pleased to announce that it will be presenting at the 12th DNB Nordic Healthcare Conference on 16th December 2021. The presentation will take place from 11:35 CET and will be made available on the Company website: www.bergenbio.com/investors/presentations/   -End-     Contacts Martin Olin CEO, BerGenBio ASA ir@bergenbio.com Rune Skeie, CFO, BerGenBio

Knowit acquires design and tech agencies in Copenhagen

Knowit AB (publ) is acquiring the Danish design agency 1508 AS and the tech agency Strømlin ApS. The new operations, combined with the business area Knowit Experience’s existing operations in Copenhagen and Aarhus, will create a strong platform for continued growth on the Danish market. The companies’ offers complement one another well and strengthen Knowit Experience’s offer in design, consultancy, and techThe long-term demand for data-driven customer experiences is high, both as an effect of changed customer behaviors and as result of the fast development of new technology that enables

Bravida strengthens its focus on technical Facility Management in the entire Nordic region

Bravida is now strengthening its range of technical Facility Management services by concentrating them in a single Nordic FM organisation. This initiative will strengthen the overall range of services across the entire service area.The new Nordic solution for technical Facility Management will ensure reliable delivery with a long-term perspective for all customers in the Nordic region. Having a unified FM organisation will make it possible for Bravida to offer tailor-made solutions based on its core competencies. “It is interesting to see how the market has changed, from featuring

There are no items matching the current filter
There are no more items matching the current filter
Back to top